157 related articles for article (PubMed ID: 10233908)
1. Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity.
Montagna D; Yvon E; Calcaterra V; Comoli P; Locatelli F; Maccario R; Fisher A; Cavazzana-Calvo M
Blood; 1999 May; 93(10):3550-7. PubMed ID: 10233908
[TBL] [Abstract][Full Text] [Related]
2. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.
Amrolia PJ; Muccioli-Casadei G; Yvon E; Huls H; Sili U; Wieder ED; Bollard C; Michalek J; Ghetie V; Heslop HE; Molldrem JJ; Rooney CM; Schlinder J; Vitetta E; Brenner MK
Blood; 2003 Sep; 102(6):2292-9. PubMed ID: 12763937
[TBL] [Abstract][Full Text] [Related]
4. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
5. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
6. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J
Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071
[TBL] [Abstract][Full Text] [Related]
7. CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.
Mutis T; Schrama E; Melief CJ; Goulmy E
Blood; 1998 Sep; 92(5):1677-84. PubMed ID: 9716596
[TBL] [Abstract][Full Text] [Related]
8. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.
Filipovich AH; Vallera D; McGlave P; Polich D; Gajl-Peczalska K; Haake R; Lasky L; Blazar B; Ramsay NK; Kersey J
Transplantation; 1990 Sep; 50(3):410-5. PubMed ID: 1698319
[TBL] [Abstract][Full Text] [Related]
9. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
Lucas KG; Small TN; Heller G; Dupont B; O'Reilly RJ
Blood; 1996 Mar; 87(6):2594-603. PubMed ID: 8630428
[TBL] [Abstract][Full Text] [Related]
10. Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin.
Cavazzana-Calvo M; Fromont C; Le Deist F; Lusardi M; Coulombel L; Derocq JM; Gerota I; Griscelli C; Fischer A
Transplantation; 1990 Jul; 50(1):1-7. PubMed ID: 2142343
[TBL] [Abstract][Full Text] [Related]
11. Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.
Hartwig UF; Nonn M; Khan S; Meyer RG; Huber C; Herr W
Bone Marrow Transplant; 2006 Feb; 37(3):297-305. PubMed ID: 16327814
[TBL] [Abstract][Full Text] [Related]
12. Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation.
Mavroudis DA; Jiang YZ; Hensel N; Lewalle P; Couriel D; Kreitman RJ; Pastan I; Barrett AJ
Bone Marrow Transplant; 1996 May; 17(5):793-9. PubMed ID: 8733700
[TBL] [Abstract][Full Text] [Related]
13. Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.
Wehler TC; Nonn M; Brandt B; Britten CM; Gröne M; Todorova M; Link I; Khan SA; Meyer RG; Huber C; Hartwig UF; Herr W
Blood; 2007 Jan; 109(1):365-73. PubMed ID: 16931626
[TBL] [Abstract][Full Text] [Related]
14. Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific anti-interleukin-2 receptor Bk chain immunotoxin.
Valteau-Couanet D; Cavazzana-Calvo M; Le Deist F; Fromont C; Fischer A
Transplantation; 1993 Dec; 56(6):1574-6. PubMed ID: 8279044
[No Abstract] [Full Text] [Related]
15. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.
Jiang YZ; Kanfer EJ; Macdonald D; Cullis JO; Goldman JM; Barrett AJ
Bone Marrow Transplant; 1991 Oct; 8(4):253-8. PubMed ID: 1756322
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
Cukrová V; Dolezalová L; Loudová M; Vítek A; Starý J
Cas Lek Cesk; 1997 Feb; 136(3):80-4. PubMed ID: 9221174
[TBL] [Abstract][Full Text] [Related]
17. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
18. Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia.
Montagna D; Maccario R; Locatelli F; Montini E; Pagani S; Bonetti F; Daudt L; Turin I; Lisini D; Garavaglia C; Dellabona P; Casorati G
Blood; 2006 Dec; 108(12):3843-50. PubMed ID: 16868250
[TBL] [Abstract][Full Text] [Related]
19. Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin.
Lee SC; Seo KW; Kim HJ; Kang SW; Choi HJ; Kim A; Kwon BS; Cho HR; Kwon B
Cell Transplant; 2015; 24(6):1167-81. PubMed ID: 24594433
[TBL] [Abstract][Full Text] [Related]
20. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
Davies JK; Koh MB; Lowdell MW
Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]